シスタチンC測定法の世界市場規模調査＆予測、製品タイプ別、測定法別、サンプルタイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年

シスタチンC測定法の世界市場は、2022年に約3億5,070万米ドルと評価され、予測期間2023-2030年には7.5％以上の健全な成長率で成長すると予測されています。

シスタチンC測定法は、血液中のシスタチンC濃度を測定する診断検査であり、細胞で産生され腎臓でろ過されるタンパク質です。シスタチンCは、従来の腎機能測定に比べ、年齢や筋肉量の影響を受けにくいです。この検査は腎障害のモニタリング、糸球体濾過率の測定、腎機能の評価に有用です。この検査は一般的な腎臓の健康状態に関する重要な情報を提供し、医療従事者が治療の選択に役立てたり、腎臓に関連する問題のリスクを評価したりするために使用されます。腎臓病の有病率の増加、政府の支援政策、ヘルスケア支出の急増、バイオテクノロジーとバイオ医薬品産業の盛んな成長は、世界中の市場需要を強化している最も顕著な要因です。

さらに、慢性腎臓病の増加もシスタチンC測定器市場を押し上げると予想されます。米国疾病予防管理センター（CDC）の2022年報告書によると、米国成人の14％以上、約3,700万人がCKDに罹患していることが明らかになっています。その結果、世界中で慢性腎臓病の有病率が上昇しており、シスタチンC濃度を測定する信頼性の高い診断ソリューションに対する需要が高まっており、市場拡大を後押ししています。また、高齢者人口の増加は、免疫力の低下によりCKDや様々な慢性疾患に罹患しやすくなるため、市場拡大のための様々な成長見通しを示しています。国連によると、2019年の世界の65歳以上の高齢者は7億300万人です。高齢者の数は2050年までに倍増し、15億人に達すると予測されています。そのため、シスタチンC測定の需要は、世界人口の高齢化とともに慢性腎臓病の罹患率が増加するにつれて増加すると予想されます。さらに、ポイント・オブ・ケア検査の採用が増加し、病態特異的バイオマーカーや検査の開発に注目が集まっていることから、予測期間中にさまざまな有利な機会がもたらされます。しかし、シスタチンC測定法の開発コストが高く、シスタチンC測定器および消耗品の承認要件が厳しいことが、2023～2030年の予測期間を通じて市場成長の妨げとなっています。

シスタチンC測定法の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、厳しい規制基準、ヘルスケア支出の増加動向、慢性腎臓病の有病率の増加、高齢者人口の増加、シスタチンC測定法を専門とするメーカーの高い存在感などにより、2022年の市場を独占しました。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されています。健康意識の高まり、ヘルスケア支出の増加、医療ツーリズムの成長、高齢者人口の拡大が、同地域全体の市場需要を大きく押し上げています。高齢者人口の増加は、腎臓疾患の高い発生率と関連しています。その結果、高齢者層の拡大につながる腎臓疾患の増加が、シスタチンC測定製品に対する需要を直接刺激しています。このことが、主要な業界企業による研究開発活動や戦略的イニシアチブの拡大を促しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 シスタチンC測定法の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の発展
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 世界のシスタチンC測定法市場力学

• シスタチンC測定法市場の影響分析（2020-2030年）
  • 市場促進要因
    • 政府の支援政策
    • 慢性腎臓病の増加と高齢化の進展
  • 市場の課題
    • シスタチンC測定法の開発コストの高さ
    • シスタチンC測定装置および消耗品の承認に対する厳しい要件
  • 市場機会
    • ポイントオブケア検査の採用増加
    • 疾患特異的バイオマーカーおよび検査の開発への注目の高まり

第4章 世界のシスタチンC測定法市場産業分析

• ポーターのファイブフォースモデル
• ポーターのファイブフォース影響分析
• PEST分析
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 シスタチンC測定の世界市場：製品別

• 市場スナップショット
• シスタチンC測定法の世界市場：製品別、実績 - ポテンシャル分析
• シスタチンC測定法の世界市場、製品別推定・予測 2020-2030年
• シスタチンC測定法市場：サブセグメント分析
  • 分析装置
  • キット
  • 試薬

第6章 シスタチンC測定法の世界市場：測定法別

• 市場スナップショット
• シスタチンC測定法の世界市場：メソッド別、実績 - ポテンシャル分析
• シスタチンC測定法の世界市場：メソッド別推定・予測 2020-2030年
• シスタチンC測定法市場：サブセグメント分析
  • 酵素結合免疫吸着測定法（ELISA法）
  • 粒子増強比濁免疫測定法（PETIA）
  • 粒子増強ネフェロメトリック免疫測定法（PENIA）
  • 化学発光免疫測定法（CLIA）
  • 蛍光免疫測定法（IFA）
  • その他

第7章 シスタチンC測定の世界市場：サンプルタイプ別

• 市場スナップショット
• シスタチンC測定法の世界市場：サンプルタイプ別、実績 - ポテンシャル分析
• シスタチンC測定法の世界市場：サンプルタイプ別推定・予測 2020-2030年
• シスタチンC測定法の世界市場：サブセグメント別分析
  • 血液
  • 尿

第8章 シスタチンC測定試薬の世界市場：用途別

• 市場スナップショット
• シスタチンC測定法の世界市場、用途別実績-ポテンシャル分析
• シスタチンC測定法の世界市場、用途別推定・予測 2020-2030年
• シスタチンC測定法の世界市場：サブセグメント別分析
  • 診断薬
  • 調査

第9章 シスタチンC測定法市場：エンドユーザー別

• 市場スナップショット
• シスタチンC測定法の世界市場：エンドユーザー別、実績 - ポテンシャル分析
• シスタチンC測定法の世界市場：エンドユーザー別推定・予測2020-2030年
• シスタチンC測定法の世界市場：サブセグメント別分析
  • 病院
  • 臨床研究所
  • 製薬会社、バイオテクノロジー企業、CRO、学術研究機関

第10章 シスタチンC測定試薬の世界市場：地域別分析

• 主要国
• 主な新興国
• シスタチンC測定法の世界市場、地域別市場スナップショット
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第11章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Abbott（US）
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Roche Diagnostics Limited（Switzerland）
  • Siemens Healthineers AG（Germany）
  • Thermo Fisher Scientific Inc.（US）
  • Randox Laboratories Ltd.（UK）
  • DiaSys Diagnostic Systems GmbH（Germany）
  • Bio-Techne（US）
  • Gentian Diagnostics ASA（Norway）
  • Getein Biotech, Inc.（China）
  • Agilent Technologies, Inc.（US）

第12章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Cystatin C Assay Market, report scope
• TABLE 2. Global Cystatin C Assay Market estimates & forecasts by Region 2020-2030 (USD Million)
• TABLE 3. Global Cystatin C Assay Market estimates & forecasts by Product 2020-2030 (USD Million)
• TABLE 4. Global Cystatin C Assay Market estimates & forecasts by Method 2020-2030 (USD Million)
• TABLE 5. Global Cystatin C Assay Market estimates & forecasts by Sample Type 2020-2030 (USD Million)
• TABLE 6. Global Cystatin C Assay Market estimates & forecasts by Application 2020-2030 (USD Million)
• TABLE 7. Global Cystatin C Assay Market estimates & forecasts by End-user 2020-2030 (USD Million)
• TABLE 8. Global Cystatin C Assay Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 9. Global Cystatin C Assay Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 10. Global Cystatin C Assay Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 11. Global Cystatin C Assay Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 12. Global Cystatin C Assay Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 13. Global Cystatin C Assay Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 14. Global Cystatin C Assay Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 15. Global Cystatin C Assay Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 16. Global Cystatin C Assay Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 17. Global Cystatin C Assay Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 18. U.S. Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 19. U.S. Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 20. U.S. Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 21. Canada Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 22. Canada Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 23. Canada Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 24. UK Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 25. UK Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 26. UK Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 27. Germany Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 28. Germany Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 29. Germany Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 30. France Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 31. France Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 32. France Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 33. Italy Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 34. Italy Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 35. Italy Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 36. Spain Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 37. Spain Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 38. Spain Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 39. RoE Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 40. RoE Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 41. RoE Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 42. China Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 43. China Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 44. China Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 45. India Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 46. India Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 47. India Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 48. Japan Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 49. Japan Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 50. Japan Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 51. South Korea Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 52. South Korea Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 53. South Korea Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 54. Australia Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 55. Australia Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 56. Australia Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 57. RoAPAC Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 58. RoAPAC Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 59. RoAPAC Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 60. Brazil Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 61. Brazil Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 62. Brazil Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 63. Mexico Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 64. Mexico Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 65. Mexico Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 66. RoLA Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 67. RoLA Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 68. RoLA Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 69. Saudi Arabia Cystatin C Assay Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 70. South Africa Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 71. RoMEA Cystatin C Assay Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 72. List of secondary sources, used in the study of global Cystatin C Assay Market
• TABLE 73. List of primary sources, used in the study of global Cystatin C Assay Market
• TABLE 74. Years considered for the study
• TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Cystatin C Assay Market, research methodology
• FIG 2. Global Cystatin C Assay Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Cystatin C Assay Market, key trends 2022
• FIG 5. Global Cystatin C Assay Market, growth prospects 2023-2030
• FIG 6. Global Cystatin C Assay Market, porters 5 force model
• FIG 7. Global Cystatin C Assay Market, pest analysis
• FIG 8. Global Cystatin C Assay Market, value chain analysis
• FIG 9. Global Cystatin C Assay Market by segment, 2020 & 2030 (USD Million)
• FIG 10. Global Cystatin C Assay Market by segment, 2020 & 2030 (USD Million)
• FIG 11. Global Cystatin C Assay Market by segment, 2020 & 2030 (USD Million)
• FIG 12. Global Cystatin C Assay Market by segment, 2020 & 2030 (USD Million)
• FIG 13. Global Cystatin C Assay Market by segment, 2020 & 2030 (USD Million)
• FIG 14. Global Cystatin C Assay Market, regional snapshot 2020 & 2030
• FIG 15. North America Cystatin C Assay Market 2020 & 2030 (USD Million)
• FIG 16. Europe Cystatin C Assay Market 2020 & 2030 (USD Million)
• FIG 17. Asia pacific Cystatin C Assay Market 2020 & 2030 (USD Million)
• FIG 18. Latin America Cystatin C Assay Market 2020 & 2030 (USD Million)
• FIG 19. Middle East & Africa Cystatin C Assay Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Cystatin C Assay Market is valued at approximately USD 350.70 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% during the forecast period 2023-2030. The Cystatin C assay is a diagnostic test that measures the levels of cystatin C in the blood, a protein produced by cells and filtered through the kidneys. Cystatin C is less affected by age and muscle mass compared to conventional kidney function measures. This test is useful for monitoring kidney disorders, determining the glomerular filtration rate, and evaluating renal function. It offers vital information about general renal health and is used by medical practitioners to inform treatment choices and assess the risk of issues connected to the kidneys. The increasing prevalence of kidney diseases, supportive government policies, surge in healthcare expenditure, as well as flourishing growth of the biotechnology and biopharmaceutical industries, are the most prominent factors that are bolstering the market demand across the globe.

Additionally, the growing incidences of chronic kidney diseases are expected to boost the Cystatin C Assay Market. A 2022 report from the Centers for Disease Control and Prevention (CDC) reveals that over 14% of U.S. adults, approximately 37 million individuals, suffer from CKD. Consequently, with the rising prevalence of chronic kidney diseases worldwide, there is an increasing demand for reliable diagnostic solutions to measure cystatin C concentration, thereby propelling market expansion. Also, the growing geriatric population base is further presenting various growth prospects for market expansion as they are more prone to be affected by the CKD and various chronic diseases due to their weak immune system. As per the United Nations, there were 703 million persons aged 65 years or over in the world in 2019. The figure for aged persons is projected to get double and reach 1.5 billion by 2050. Thereby, the demand for cystatin C assays is expected to increase as the growing incidences of chronic kidney diseases, along with the global population age. Moreover, the increasing adoption of point of care testing, as well as the rising focus on the development of condition-specific biomarkers and tests presents various lucrative opportunities over the forecast years. However, the high development costs of cystatin C assays and stringent requirements for approval of cystatin C assay instruments and consumables are hindering market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cystatin C Assay Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the stringent regulatory standards, an increasing trend in healthcare expenditure, the growing prevalence of chronic kidney diseases, the increasing elderly population, and the high presence of manufacturers specializing in cystatin C assays. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The surge in health awareness, escalating healthcare spending, the growth of medical tourism, and the expanding geriatric demographic are significantly propelling the market demand across the region. The rise in the elderly population is associated with a higher incidence of nephros diseases. Consequently, the increase in kidney diseases leading to the expansion of this demographic is directly stimulating the demand for cystatin C assay products. This, in turn, is fostering growing research and development activities and strategic initiatives by key industry players.

Major market players included in this report are:

• Abbott (US)
• Roche Diagnostics Limited (Switzerland)
• Siemens Healthineers AG (Germany)
• Thermo Fisher Scientific Inc. (US)
• Randox Laboratories Ltd. (UK)
• DiaSys Diagnostic Systems GmbH (Germany)
• Bio-Techne (US)
• Gentian Diagnostics ASA (Norway)
• Getein Biotech, Inc. (China)
• Agilent Technologies, Inc. (US)

Recent Developments in the Market:

• In March 2021, Roche completed the acquisition of GenMark Diagnostics, purchasing each share for USD 24.05 and achieving a total transaction value of USD 1.8 billion. This strategic move significantly bolstered Roche's Diagnostics portfolio.
• In March 2022, Gentian- a leading participant in the cystatin C test industry announced that TuV SUD has validated their GCAL and Cystatin C assays for IVDR (In-Vitro Diagnostic Regulation). The assays meet the regulatory requirements outlined by IVDR, as indicated by this certification. This strategic introduction aimed to increase income and broaden its services.

Global Cystatin C Assay Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Method, Sample Type, Application, End-user, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Analyzers
• Kits
• Reagents

By Method:

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Particle-Enhanced Turbidimetric Immunoassay (PETIA)
• Particle-enhanced Nephelometric Immunoassay (PENIA)
• Chemiluminescent immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Others

By Sample Type:

• Blood
• Urine

By Application:

• Diagnostics
• Research

By End-user:

• Hospitals
• Clinical Laboratories
• Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Cystatin C Assay Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Cystatin C Assay Market, by Product, 2020-2030 (USD Million)
  • 1.2.3. Cystatin C Assay Market, by Method, 2020-2030 (USD Million)
  • 1.2.4. Cystatin C Assay Market, by Sample Type, 2020-2030 (USD Million)
  • 1.2.5. Cystatin C Assay Market, by Application, 2020-2030 (USD Million)
  • 1.2.6. Cystatin C Assay Market, by End-user, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Cystatin C Assay Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Cystatin C Assay Market Dynamics

• 3.1. Cystatin C Assay Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Supportive government policies
    • 3.1.1.2. Rising incidences of chronic kidney diseases and increasing aging population
  • 3.1.2. Market Challenges
    • 3.1.2.1. High development costs of cystatin C assays
    • 3.1.2.2. Stringent requirements for approval of cystatin C assay instruments and consumables
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing adoption of point of care testing
    • 3.1.3.2. Rising focus on the development of condition-specific biomarkers and tests

Chapter 4. Global Cystatin C Assay Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cystatin C Assay Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Cystatin C Assay Market by Product, Performance - Potential Analysis
• 5.3. Global Cystatin C Assay Market Estimates & Forecasts by Product 2020-2030 (USD Million)
• 5.4. Cystatin C Assay Market, Sub Segment Analysis
  • 5.4.1. Analyzers
  • 5.4.2. Kits
  • 5.4.3. Reagents

Chapter 6. Global Cystatin C Assay Market, by Method

• 6.1. Market Snapshot
• 6.2. Global Cystatin C Assay Market by Method, Performance - Potential Analysis
• 6.3. Global Cystatin C Assay Market Estimates & Forecasts by Method 2020-2030 (USD Million)
• 6.4. Cystatin C Assay Market, Sub Segment Analysis
  • 6.4.1. Enzyme-Linked Immunosorbent Assay (ELISA)
  • 6.4.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  • 6.4.3. Particle-enhanced Nephelometric Immunoassay (PENIA)
  • 6.4.4. Chemiluminescent immunoassay (CLIA)
  • 6.4.5. Immunofluorescence assay (IFA)
  • 6.4.6. Others

Chapter 7. Global Cystatin C Assay Market, by Sample Type

• 7.1. Market Snapshot
• 7.2. Global Cystatin C Assay Market by Sample Type, Performance - Potential Analysis
• 7.3. Global Cystatin C Assay Market Estimates & Forecasts by Sample Type 2020-2030 (USD Million)
• 7.4. Cystatin C Assay Market, Sub Segment Analysis
  • 7.4.1. Blood
  • 7.4.2. Urine

Chapter 8. Global Cystatin C Assay Market, by Application

• 8.1. Market Snapshot
• 8.2. Global Cystatin C Assay Market by Application, Performance - Potential Analysis
• 8.3. Global Cystatin C Assay Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 8.4. Cystatin C Assay Market, Sub Segment Analysis
  • 8.4.1. Diagnostics
  • 8.4.2. Research

Chapter 9. Cystatin C Assay Market, by End-user

• 9.1. Market Snapshot
• 9.2. Global Cystatin C Assay Market by End-user, Performance - Potential Analysis
• 9.3. Global Cystatin C Assay Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
• 9.4. Cystatin C Assay Market, Sub Segment Analysis
  • 9.4.1. Hospitals
  • 9.4.2. Clinical Laboratories
  • 9.4.3. Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes

Chapter 10. Global Cystatin C Assay Market, Regional Analysis

• 10.1. Top Leading Countries
• 10.2. Top Emerging Countries
• 10.3. Cystatin C Assay Market, Regional Market Snapshot
• 10.4. North America Cystatin C Assay Market
  • 10.4.1. U.S. Cystatin C Assay Market
    • 10.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 10.4.1.2. Method breakdown estimates & forecasts, 2020-2030
    • 10.4.1.3. Sample Type breakdown estimates & forecasts, 2020-2030
    • 10.4.1.4. Application breakdown estimates & forecasts, 2020-2030
    • 10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
  • 10.4.2. Canada Cystatin C Assay Market
• 10.5. Europe Cystatin C Assay Market Snapshot
  • 10.5.1. U.K. Cystatin C Assay Market
  • 10.5.2. Germany Cystatin C Assay Market
  • 10.5.3. France Cystatin C Assay Market
  • 10.5.4. Spain Cystatin C Assay Market
  • 10.5.5. Italy Cystatin C Assay Market
  • 10.5.6. Rest of Europe Cystatin C Assay Market
• 10.6. Asia-Pacific Cystatin C Assay Market Snapshot
  • 10.6.1. China Cystatin C Assay Market
  • 10.6.2. India Cystatin C Assay Market
  • 10.6.3. Japan Cystatin C Assay Market
  • 10.6.4. Australia Cystatin C Assay Market
  • 10.6.5. South Korea Cystatin C Assay Market
  • 10.6.6. Rest of Asia Pacific Cystatin C Assay Market
• 10.7. Latin America Cystatin C Assay Market Snapshot
  • 10.7.1. Brazil Cystatin C Assay Market
  • 10.7.2. Mexico Cystatin C Assay Market
• 10.8. Middle East & Africa Cystatin C Assay Market
  • 10.8.1. Saudi Arabia Cystatin C Assay Market
  • 10.8.2. South Africa Cystatin C Assay Market
  • 10.8.3. Rest of Middle East & Africa Cystatin C Assay Market

Chapter 11. Competitive Intelligence

• 11.1. Key Company SWOT Analysis
  • 11.1.1. Company 1
  • 11.1.2. Company 2
  • 11.1.3. Company 3
• 11.2. Top Market Strategies
• 11.3. Company Profiles
  • 11.3.1. Abbott (US)
    • 11.3.1.1. Key Information
    • 11.3.1.2. Overview
    • 11.3.1.3. Financial (Subject to Data Availability)
    • 11.3.1.4. Product Summary
    • 11.3.1.5. Recent Developments
  • 11.3.2. Roche Diagnostics Limited (Switzerland)
  • 11.3.3. Siemens Healthineers AG(Germany)
  • 11.3.4. Thermo Fisher Scientific Inc. (US)
  • 11.3.5. Randox Laboratories Ltd. (UK)
  • 11.3.6. DiaSys Diagnostic Systems GmbH (Germany)
  • 11.3.7. Bio-Techne (US)
  • 11.3.8. Gentian Diagnostics ASA (Norway)
  • 11.3.9. Getein Biotech, Inc. (China)
  • 11.3.10. Agilent Technologies, Inc. (US)

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption